Koekkoek, W. A. C.
Menger, Y. A.
van Zanten, F. J. L.
van Dijk, D.
van Zanten, A. R. H.
Article History
Received: 9 June 2019
Accepted: 16 January 2020
First Online: 3 February 2020
Ethics approval and consent to participate
: The institutional review board of Gelderse Vallei Hospital approved the study and waived informed consent for reasons of the retrospective design and anonymization of patient identifiers before analysis.
: Not applicable.
: Arthur van Zanten reported that he has received honoraria for advisory board meetings, lectures, and travel expenses from Abbott, Baxter, BBraun, Danone-Nutricia, Fresenius Kabi, Mermaid, Lyric, and Nestle -Novartis. Inclusion fees for patients in nutrition trials were paid to the local ICU research foundation. The remaining authors declare that they have no competing interests.